OIA
EVOK

Optimum Investment Advisors’s Evoke Pharma EVOK Stock Holding History

Optimum Investment Advisors’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6
Closed -$3K – 889
2020
Q2 		$3K Buy
+6
New +$1.67K ﹤0.01% 778

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
WA
Wambolt & Associates Littleton, Colorado $297M AUM 17.23% 1-Year Est. Return

Optimum Investment Advisors's EVOK Position: Q3 2020 in Review

Optimum Investment Advisors sold out of Evoke Pharma (EVOK) in Q3 2020, closing a stake of 6 shares — an estimated $3K sold.

Optimum Investment Advisors first reported a position in EVOK in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 25 funds tracked by Wall St. Rank hold EVOK as of Q3 2020.

  • Optimum Investment Advisors reported no remaining Evoke Pharma position as of Q3 2020 after selling out during the quarter.
  • Optimum Investment Advisors sold 6 Evoke Pharma shares in Q3 2020, an estimated $3K.
  • Optimum Investment Advisors first reported a position in Evoke Pharma in Q2 2020 and held it in 1 quarter.
  • Optimum Investment Advisors's Evoke Pharma position peaked at $3K in Q2 2020.
  • 25 funds tracked by Wall St. Rank held Evoke Pharma as of Q3 2020.

Based on Optimum Investment Advisors's 13F filing for Q3 2020, filed 6 Oct 2020.